Table 2.
Association between TGFA Taq1 polymorphism and CL/P risk
| Model | Number of studies | Fixed effect | Random effect | Phet | I-squared (%) |
|---|---|---|---|---|---|
| C1C2 vs. C1C1 |
12 |
1.46 [1.22,1.75] |
1.67 [1.23,2.25] |
0.009 |
55.8 |
| C2C2 vs. C1C1 |
12 |
1.57 [0.87,2.83] |
1.56 [0.78,3.16] |
0.525 |
0.0 |
| C1C2 + C2C2 vs. C1C1 |
14 |
1.33 [1.14,1.54] |
1.52 [1.15,2.01] |
0.000 |
64.7 |
| C2C2 vs. C1C2 + C1C1 |
12 |
1.43 [0.79,2.59] |
1.42 [0.70,2.85] |
0.634 |
0.0 |
| C2 vs. C1 | 18 | 1.26 [1.12,1.43] | 1.41 [1.12,1.78] | 0.000 | 65.2 |